vs
GLAUKOS Corp（GKOS）与PROCEPT BioRobotics Corp（PRCT）财务数据对比。点击上方公司名可切换其他公司
GLAUKOS Corp的季度营收约是PROCEPT BioRobotics Corp的1.8倍（$150.6M vs $83.1M），GLAUKOS Corp净利率更高（6.2% vs -38.1%，领先44.3%），GLAUKOS Corp同比增速更快（41.2% vs 20.2%），过去两年GLAUKOS Corp的营收复合增速更高（25.4% vs 24.8%）
Glaukos Corp是一家专注于眼科领域的医疗科技企业，开发并商业化用于治疗青光眼、角膜疾病等眼部病症的微创手术器械、处方药物及消费级产品，主要市场覆盖北美、欧洲及亚太地区，为全球医院、眼科诊所及患者提供服务。
PROCEPT BioRobotics是一家专注于研发和商业化泌尿外科手术机器人解决方案的医疗科技企业，其旗舰AquaBeam系统可为良性前列腺增生患者提供图像引导微创治疗，服务覆盖北美、欧洲等地区的医疗机构与患者。
GKOS vs PRCT — 直观对比
营收规模更大
GKOS
是对方的1.8倍
$83.1M
营收增速更快
GKOS
高出21.0%
20.2%
净利率更高
GKOS
高出44.3%
-38.1%
两年增速更快
GKOS
近两年复合增速
24.8%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $150.6M | $83.1M |
| 净利润 | $9.4M | $-31.6M |
| 毛利率 | 77.9% | 64.9% |
| 营业利润率 | 9.0% | -4.1% |
| 净利率 | 6.2% | -38.1% |
| 营收同比 | 41.2% | 20.2% |
| 净利润同比 | — | -27.9% |
| 每股收益（稀释后） | — | $-0.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GKOSPRCT
| Q1 26 | $150.6M | $83.1M | ||
| Q4 25 | $143.1M | $76.4M | ||
| Q3 25 | $133.5M | $83.3M | ||
| Q2 25 | $124.1M | $79.2M | ||
| Q1 25 | $106.7M | $69.2M | ||
| Q4 24 | $105.5M | $68.2M | ||
| Q3 24 | $96.7M | $58.4M | ||
| Q2 24 | $95.7M | $53.4M |
净利润GKOSPRCT
| Q1 26 | $9.4M | $-31.6M | ||
| Q4 25 | $-133.7M | $-29.8M | ||
| Q3 25 | $-16.2M | $-21.4M | ||
| Q2 25 | $-19.7M | $-19.6M | ||
| Q1 25 | $-18.1M | $-24.7M | ||
| Q4 24 | $-33.6M | $-18.9M | ||
| Q3 24 | $-21.4M | $-21.0M | ||
| Q2 24 | $-50.5M | $-25.6M |
毛利率GKOSPRCT
| Q1 26 | 77.9% | 64.9% | ||
| Q4 25 | -1.1% | 60.6% | ||
| Q3 25 | 78.4% | 64.8% | ||
| Q2 25 | 78.3% | 65.4% | ||
| Q1 25 | 77.2% | 63.9% | ||
| Q4 24 | 72.9% | 64.0% | ||
| Q3 24 | 76.6% | 63.2% | ||
| Q2 24 | 76.4% | 59.0% |
营业利润率GKOSPRCT
| Q1 26 | 9.0% | -4.1% | ||
| Q4 25 | -97.7% | -40.6% | ||
| Q3 25 | -12.3% | -27.8% | ||
| Q2 25 | -18.3% | -28.0% | ||
| Q1 25 | -19.4% | -39.7% | ||
| Q4 24 | -27.2% | -28.9% | ||
| Q3 24 | -25.5% | -38.4% | ||
| Q2 24 | -31.3% | -50.3% |
净利率GKOSPRCT
| Q1 26 | 6.2% | -38.1% | ||
| Q4 25 | -93.4% | -39.1% | ||
| Q3 25 | -12.2% | -25.7% | ||
| Q2 25 | -15.8% | -24.7% | ||
| Q1 25 | -17.0% | -35.8% | ||
| Q4 24 | -31.8% | -27.6% | ||
| Q3 24 | -22.1% | -35.9% | ||
| Q2 24 | -52.8% | -48.0% |
每股收益（稀释后）GKOSPRCT
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $-2.34 | $-0.54 | ||
| Q3 25 | $-0.28 | $-0.38 | ||
| Q2 25 | $-0.34 | $-0.35 | ||
| Q1 25 | $-0.32 | $-0.45 | ||
| Q4 24 | $-0.56 | $-0.34 | ||
| Q3 24 | $-0.39 | $-0.40 | ||
| Q2 24 | $-1.00 | $-0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $276.7M | $245.6M |
| 总债务越低越好 | — | $51.7M |
| 股东权益账面价值 | $670.9M | $347.7M |
| 总资产 | $893.3M | $487.1M |
| 负债/权益比越低杠杆越低 | — | 0.15× |
8季度趋势，按日历期对齐
现金及短期投资GKOSPRCT
| Q1 26 | $276.7M | $245.6M | ||
| Q4 25 | $90.8M | $286.5M | ||
| Q3 25 | $98.2M | $294.3M | ||
| Q2 25 | $100.8M | $302.7M | ||
| Q1 25 | $114.3M | $316.2M | ||
| Q4 24 | $169.6M | $333.7M | ||
| Q3 24 | $100.1M | $196.8M | ||
| Q2 24 | $68.1M | $214.1M |
总债务GKOSPRCT
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
股东权益GKOSPRCT
| Q1 26 | $670.9M | $347.7M | ||
| Q4 25 | $656.2M | $365.9M | ||
| Q3 25 | $769.5M | $380.3M | ||
| Q2 25 | $765.1M | $385.8M | ||
| Q1 25 | $764.0M | $389.2M | ||
| Q4 24 | $766.9M | $402.2M | ||
| Q3 24 | $668.5M | $241.2M | ||
| Q2 24 | $665.2M | $251.8M |
总资产GKOSPRCT
| Q1 26 | $893.3M | $487.1M | ||
| Q4 25 | $893.5M | $508.1M | ||
| Q3 25 | $999.4M | $511.5M | ||
| Q2 25 | $987.0M | $513.1M | ||
| Q1 25 | $966.2M | $519.4M | ||
| Q4 24 | $974.8M | $534.0M | ||
| Q3 24 | $926.5M | $374.1M | ||
| Q2 24 | $919.7M | $374.4M |
负债/权益比GKOSPRCT
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GKOS
暂无分部数据
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
